Consolidated Statements Of Changes In Stockholders’ Equity - USD ($)	Common Stock [Member]	Surplus [Member]	Retained Earnings [Member] Cumulative Effect, Period of Adoption, Adjustment [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]	Total
Beginning balance at Dec. 31, 2022	$ 829,000	$ 96,897,000	$ (2,011,000)	$ 130,020,000	$ (3,308,000)	$ (57,353,000)	$ (2,011,000)	$ 167,085,000
Beginning balance, shares at Dec. 31, 2022	8,291,401				124,650
Net Income				5,782,000				5,782,000
Other comprehensive loss						7,390,000		7,390,000
Cash dividends declared				(2,375,000)				(2,375,000)
Compensation expense related to restricted stock		114,000						114,000
Stock options exercised		(44,000)			$ 378,000			334,000
Stock options exercised, shares					(14,250)
Compensation expense related to stock options		96,000						96,000
Ending balance, shares at Mar. 31, 2023	8,291,401				110,400
Ending balance at Mar. 31, 2023	$ 829,000	97,063,000		131,416,000	$ (2,930,000)	(49,963,000)		176,415,000
Beginning balance at Dec. 31, 2023	$ 831,000	97,700,000		135,284,000	$ (5,397,000)	(47,348,000)		$ 181,070,000
Beginning balance, shares at Dec. 31, 2023	8,310,847				200,690
Accounting Standards Update [Extensible Enumeration]								us-gaap:AccountingStandardsUpdate201613Member
Net Income				4,433,000				$ 4,433,000
Other comprehensive loss						(2,051,000)		(2,051,000)
Cash dividends declared				(2,432,000)				(2,432,000)
Compensation expense related to restricted stock		104,000						104,000
Compensation expense related to stock options		89,000						89,000
Ending balance, shares at Mar. 31, 2024	8,310,847				200,690
Ending balance at Mar. 31, 2024	$ 831,000	$ 97,893,000		$ 137,285,000	$ (5,397,000)	$ (49,399,000)		$ 181,213,000